FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002249933> ?p ?o ?g. }

• W2002249933 endingPage "391" @default.
• W2002249933 startingPage "387" @default.
• W2002249933 abstract "Background/Aim. Tibolone is a preparation that belongs to the group of steroidal substances. The effects of the use of the use of tibolone are the consequence of the activities of its metabolities, considering that their hormonal activity depends on the type of tissue in which they develop. The aim of this study was to evaluate the influence of the use of tibolone on risk factors for the development of cardiovascular diseases in postmenopausal women. Methods. A prospective observational stady included 94 patients who had the concentration of l7? estradiol < 50 pg/ml, and who was in menopause more than a year. Out of the total number of patients, 63 accepted to receive tibolone 2.5 mg daily (tibolone group), while 31 of the patients refused to take tibolone (control group). We measured the concentration of lipids (cholesterol, LDL cholesterol, HDL cholesterol, triglicerides), antitrombin III, fibrinogen, and C-reactive protein, before and after the treatment within a 6-month period. Then, we compared the difference between the values of concentrations and tested the statistical significance of the difference. We also evaluated the changes of values in the concentrations of the examinated parameters inside a 6-month period in the control group. Results. In 31 patients of the control group, from the control group there were no significant changes in the values of the defined parameters as compared to their initial values after six months. But there were changes of statistical significance (p < 0.001) in values of the concentrations of the exeminated parameters before and after the treatment in the tibolone group. In fact, we recorded decreases in the total cholesterol by 17.8%, HDL cholesterol by 27%, LDL cholesterol by 4% (without statistical significance p > 0.05) and triglicerids by 35%. There were no statistical differences in the concentrations of antitrombin III, fibrionogen, and C-reactive proteine in the tibolone group before and after the treatment. Conclusion. The use of tibolone dose decrease the concentration of the total cholesterol, triglicerides, HDL cholesterol, without a significant decrease of LDL cholesterol. Also, the use of tibolone does not have any significant effect on the concentrations of antitrombin III, fibrinogen and C-reactive proteine. The number of serum parameters measured in this study was limited, thus that was the reason to discuss only about the metabolism of lipids in the patients from the tibolone group. The final conclusion about the risk for cardiovascular diseases in the patients on tibolone, howerer, reqnires were extensive further clinical exeminations." @default.
• W2002249933 created "2016-06-24" @default.
• W2002249933 creator A5007481427 @default.
• W2002249933 creator A5018707479 @default.
• W2002249933 creator A5019435788 @default.
• W2002249933 creator A5069255156 @default.
• W2002249933 creator A5073991455 @default.
• W2002249933 creator A5079585311 @default.
• W2002249933 date "2006-01-01" @default.
• W2002249933 modified "2023-10-16" @default.
• W2002249933 title "Effects of tibolone on the risk factors for cardiovascular diseases in postmenopausal women" @default.
• W2002249933 cites W1593442063 @default.
• W2002249933 cites W1980265299 @default.
• W2002249933 cites W1983630208 @default.
• W2002249933 cites W1988870163 @default.
• W2002249933 cites W2006353464 @default.
• W2002249933 cites W2028276927 @default.
• W2002249933 cites W2048182846 @default.
• W2002249933 cites W2060269207 @default.
• W2002249933 cites W2065264027 @default.
• W2002249933 cites W2065660647 @default.
• W2002249933 cites W2069878676 @default.
• W2002249933 cites W2092407540 @default.
• W2002249933 cites W2093652845 @default.
• W2002249933 cites W2098518124 @default.
• W2002249933 cites W2113264115 @default.
• W2002249933 cites W2115343069 @default.
• W2002249933 cites W2153643571 @default.
• W2002249933 cites W2159140695 @default.
• W2002249933 cites W2161099952 @default.
• W2002249933 cites W2332056249 @default.
• W2002249933 cites W4245245623 @default.
• W2002249933 cites W4255165612 @default.
• W2002249933 doi "https://doi.org/10.2298/vsp0604387j" @default.
• W2002249933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16683408" @default.
• W2002249933 hasPublicationYear "2006" @default.
• W2002249933 type Work @default.
• W2002249933 sameAs 2002249933 @default.
• W2002249933 citedByCount "2" @default.
• W2002249933 countsByYear W20022499332016 @default.
• W2002249933 countsByYear W20022499332017 @default.
• W2002249933 crossrefType "journal-article" @default.
• W2002249933 hasAuthorship W2002249933A5007481427 @default.
• W2002249933 hasAuthorship W2002249933A5018707479 @default.
• W2002249933 hasAuthorship W2002249933A5019435788 @default.
• W2002249933 hasAuthorship W2002249933A5069255156 @default.
• W2002249933 hasAuthorship W2002249933A5073991455 @default.
• W2002249933 hasAuthorship W2002249933A5079585311 @default.
• W2002249933 hasBestOaLocation W20022499331 @default.
• W2002249933 hasConcept C126322002 @default.
• W2002249933 hasConcept C134018914 @default.
• W2002249933 hasConcept C23131810 @default.
• W2002249933 hasConcept C2777457466 @default.
• W2002249933 hasConcept C2778163477 @default.
• W2002249933 hasConcept C2778562196 @default.
• W2002249933 hasConcept C2779036427 @default.
• W2002249933 hasConcept C3018603563 @default.
• W2002249933 hasConcept C42407357 @default.
• W2002249933 hasConcept C63363279 @default.
• W2002249933 hasConcept C65409693 @default.
• W2002249933 hasConcept C71315377 @default.
• W2002249933 hasConcept C71924100 @default.
• W2002249933 hasConceptScore W2002249933C126322002 @default.
• W2002249933 hasConceptScore W2002249933C134018914 @default.
• W2002249933 hasConceptScore W2002249933C23131810 @default.
• W2002249933 hasConceptScore W2002249933C2777457466 @default.
• W2002249933 hasConceptScore W2002249933C2778163477 @default.
• W2002249933 hasConceptScore W2002249933C2778562196 @default.
• W2002249933 hasConceptScore W2002249933C2779036427 @default.
• W2002249933 hasConceptScore W2002249933C3018603563 @default.
• W2002249933 hasConceptScore W2002249933C42407357 @default.
• W2002249933 hasConceptScore W2002249933C63363279 @default.
• W2002249933 hasConceptScore W2002249933C65409693 @default.
• W2002249933 hasConceptScore W2002249933C71315377 @default.
• W2002249933 hasConceptScore W2002249933C71924100 @default.
• W2002249933 hasIssue "4" @default.
• W2002249933 hasLocation W20022499331 @default.
• W2002249933 hasLocation W20022499332 @default.
• W2002249933 hasOpenAccess W2002249933 @default.
• W2002249933 hasPrimaryLocation W20022499331 @default.
• W2002249933 hasRelatedWork W1997759048 @default.
• W2002249933 hasRelatedWork W2010645160 @default.
• W2002249933 hasRelatedWork W2027210979 @default.
• W2002249933 hasRelatedWork W2031184539 @default.
• W2002249933 hasRelatedWork W2032958076 @default.
• W2002249933 hasRelatedWork W2042044567 @default.
• W2002249933 hasRelatedWork W2043879443 @default.
• W2002249933 hasRelatedWork W2049266444 @default.
• W2002249933 hasRelatedWork W2069420617 @default.
• W2002249933 hasRelatedWork W2164661085 @default.
• W2002249933 hasVolume "63" @default.
• W2002249933 isParatext "false" @default.
• W2002249933 isRetracted "false" @default.
• W2002249933 magId "2002249933" @default.
• W2002249933 workType "article" @default.